The Aranda Solution
A system designed to deliver – and built to endure.Aranda is a national delivery system to address the challenge of antimicrobial resistance, integrating medicines, diagnostics, surveillance, stewardship, financing, and execution into one economically viable subscription model.
Aranda builds functioning marketplaces where they do not currently exist.
By aggregating demand, pooling procurement, embedding delivery capacity, and aligning incentives across governments and manufacturers, Aranda enables countries to obtain the medicines they need while supporting appropriate use.
Our approach is designed to make antimicrobial access:
- Reliable for governments
- Sustainable for manufacturers
- Clinically responsible for health systems
- Affordable over time
- Measurable through surveillance and outcomes data
This is how Aranda turns an intractable global health challenge into a practical, locally-implemented program which achieves results.
What makes us innovative
Aranda is the first commercial vehicle to treat antimicrobial access as a coordination problem.
We are innovative in six ways:
1. We integrate disciplines that rarely combine.
Aranda brings together government delivery, pharmaceutical access, emerging-market execution, stewardship, surveillance, and an economically-viable structure.
2. We create bundled accountability.
Supply, surveillance, and stewardship are managed through one subscription with one accountable provider – yet keeps competition fierce through multiple competing suppliers.
3. We transfer risk away from governments.
Aranda absorbs supply, pricing, and volume risk through a fixed five-year price.
4. We expand the subscription model.
Rather than focusing on a single reserve drug, Aranda includes the full portfolio of antimicrobial medicines and diagnostics needed by each country – as required.
5. We create a self-funding path to scale.
The country design process is funded by Aranda, as it dissolves issues in partnerships that often impede public/private models. Surpluses from implementation can support future country design, eliminating long-term dependence on donors.
6. We align incentives across a value chain that usually fights itself.
Manufacturers and pharma companies retain their existing business model, but in addition gain LMIC revenue they currently forgo; governments spend less and deliver better health outcomes; clinicians get real-time stewardship support; patients get the right drug at the right time. No stakeholder has to lose for patients to win.
Proven methodology – delivery assurance
Working with governments, civil society, industry, and clinical stakeholders, Aranda supports access, adoption, stewardship, surveillance, and appropriate use across public and private health systems.
The approach draws on techniques pioneered in the U.K., refined in Malaysia, and deployed successfully by governments across Africa, Australia, and other geographies – combining policy, delivery, and commercial execution in one disciplined process.
CONNECT WITH US
Aranda is building an economically-viable approach to solving one of global health’s most urgent and intractable problems.